Pengbin
Li
,
Bo
Lü
,
Chunling
Fu
and
Shengming
Ma
*
Laboratory of Molecular Recognition and synthesis, Department of Chemistry, Zhejiang University, Hangzhou 310027, People's Republic of China. E-mail: masm@sioc.ac.cn; Fax: +86-21-64167510
First published on 14th September 2012
In this paper, LB-Phos·HBF4 salt has been applied for the Pd-catalysed Suzuki coupling reactions of optically active (Z)-α-choroalkylidene-β-lactones. Aryl, vinyl, alkyl and heteroaromatic boronic acids may be coupled with optically active β-lactones affording corresponding optically active products highly selectively and efficiently.
|
|
|||||
|---|---|---|---|---|---|
| Entry | 3a (equiv) | Solvent | Time (h) | Yield of (Z)-4aa (%) | Recovery of (Z)-2aa (%) |
| a Determined by 1H NMR analysis using methylene bromide as the internal standard. b K2CO3 (2.0 equiv) was used. c LB-Phos·HBF4 (5 mol%) was used. d Pd(OAc)2 (3 mol%) and LB-Phos·HBF4 (6 mol%) were used. e K3PO4·3H2O (2.0 equiv) was used. | |||||
| 1 | 1.5 | Toluene | 1.0 | 100 | — |
| 2 | 1.5 | Dioxane | 1.0 | 58 | 39 |
| 3 | 1.5 | DMF | 1.5 | — | — |
| 4 | 1.5 | DMSO | 3.2 | — | — |
| 5 | 1.2 | Toluene | 2.6 | 94 | — |
| 6b | 1.2 | Toluene | 1.2 | 77 | 23 |
| 7c | 1.2 | Toluene | 1.0 | 86 | 14 |
| 8d | 1.2 | Toluene | 1.7 | 88 | — |
| 9d,e | 1.2 | Toluene | 0.7 | 95 | — |
Optically active coupling product (S,Z)-4a could also be produced from (S,Z)-2a under our optimized reaction conditions in 98% yield with no racemization (eqn (1)). Thus, it is concluded that even such strained allylic C–O bonds may also be kept untouched.4
![]() | (1) |
Encouraged by these results, a series of optically active α-chloroalkylidene-β-lactones6 were tested under the optimized conditions (Table 2). Aromatic (Table 2, entries 1–4 and 6–10) and vinylic boronic acids (Table 2, entries 5 and 11) could all be coupled with the starting β-lactones to afford the products within 0.8–3.7 h. Increasing the steric hindrance in the ortho-position of aryl boronic acid led to longer reaction times and lower yields (Table 2, compare entries 1 and 4). 2-Naphthyl boronic acid (3g) was also used to couple with (S,Z)-2a affording (S,Z)-4h in 86% yield (Table 2, entry 8).
|
|
||||||
|---|---|---|---|---|---|---|
| Entry | (S,Z)-2 | 3 | Time (h) | Yieldb (%) | ||
| R1 | R2 | R3 | ||||
| a Standard conditions A: a mixture of 1.0 equiv of (S,Z)-2 (0.2 mmol or 0.4 mmol), 1.2 equiv of 3, 2.0 equiv of K3PO4·3H2O, 0.03 equiv of Pd(OAc)2 and 0.06 equiv of LB-Phos·HBF4 was stirred in toluene (0.1 M) at 110 °C. b Isolated yield. | ||||||
| 1 | (S,Z)-2a | n-Bu | Et | Ph (3a) | 0.8 | 98 ((S,Z)-4a) |
| 2 | (S,Z)-2a | n-Bu | Et | 4-MeOC6H4 (3b) | 2.0 | 84 ((S,Z)-4b) |
| 3 | (S,Z)-2a | n-Bu | Et | 3-MeOC6H4 (3c) | 1.0 | 77 ((S,Z)-4c) |
| 4 | (S,Z)-2a | n-Bu | Et | 2-MeOC6H4 (3d) | 3.7 | 69 ((S,Z)-4d) |
| 5 | (S,Z)-2a | n-Bu | Et | (E)-Styryl (3e) | 2.8 | 91 ((S,Z,E)-4e) |
| 6 | (S,Z)-2a | n-Bu | Et | 4-MeC6H4 (3f) | 1.0 | 93 ((S,Z)-4f) |
| 7 | (S,Z)-2b | n-Bu | Me | 4-MeC6H4 (3f) | 1.0 | 71 ((S,Z)-4g) |
| 8 | (S,Z)-2a | n-Bu | Et | 2-Naphthyl (3g) | 1.0 | 86 ((S,Z)-4h) |
| 9 | (S,Z)-2c | n-Bu | i-Pr | Ph (3a) | 1.5 | 94 ((S,Z)-4i) |
| 10 | (S,Z)-2d | Ph | Et | 4-MeOC6H4 (3b) | 1.5 | 93 ((S,Z)-4j) |
| 11 | (S,Z)-2d | Ph | Et | (E)-1-Pentenyl (3h) | 0.8 | 95 ((S,E,E)-4k) |
One 5.0 mmol-scale reaction was carried out affording (S,Z)-4b with a relatively higher yield (eqn (2)vs. entry 2, Table 2) within 2.0 h when 1 mol% Pd(OAc)2 together with 2 mol% LB-Phos·HBF4 was used as the catalyst (eqn (2)).
![]() | (2) |
However, when cyclopropylboronic acid 3i and (Z)-2d were coupled under the optimized conditions, the yield of product (E)-4l was only 23% (Table 3, entry 1).6 A higher loading of boronic acid 3i did not help to give a higher yield (Table 3, entries 2–3). The base-sensitive β-lactone (Z)-2d would decompose quickly even in absence of Pd(OAc)2 and LB-Phos·HBF4 (Table 3, entry 5). Using weaker base such as CsF and K2HPO4·3H2O gave no expected product but recovery of (Z)-2d (Table 3, entries 7 and 8).
|
|
|||||
|---|---|---|---|---|---|
| Entry | 3i (equiv) | Base | Time (h) | Yield of (E)-4la (%) | Recovery of (Z)-2da (%) |
| a Determined by 1H NMR analysis. b Neither Pd(OAc)2 nor ligand was added here. c Pd2(dba)3·CHCl3 was used to replace Pd(OAc)2. | |||||
| 1 | 1.2 | K3PO4·3H2O | 1.0 | 23 | 0 |
| 2 | 1.5 | K3PO4·3H2O | 1.8 | 17 | 0 |
| 3 | 3.0 | K3PO4·3H2O | 1.5 | 12 | <4 |
| 4b | 0.0 | K3PO4·3H2O | 1.5 | 0 | 21 |
| 5c | 1.2 | K3PO4·3H2O | 5.0 | 19 | 0 |
| 6 | 1.2 | Cs2CO3 | 1.3 | 12 | 27 |
| 7 | 1.2 | CsF | 1.1 | 0 | 83 |
| 8 | 1.2 | K2HPO4·3H2O | 6.0 | 0 | 97 |
Further screening led to the observation that when toluene–water (v/v = 5
:
1) was used as the mixed solvent, (E)-4l was obtained in 29% yield with 50% of (Z)-2d being recovered (Table 4, entry 1). Decreasing the amount of water to 1
:
10 ratio (water/toluene (v/v)) would lead to 54% yield (Table 4, entry 2). Further decreasing the amount of water did not improve the yield of (E)-4l (Table 4, entry 3).
Under the newly optimized conditions (Table 4, entry 2), cyclopropylboronic acid could couple with optically active (S,Z)-2d affording (S,E)-4l in 46% yield (eqn (3)). However, the coupling of n-butylboronic acid with (S,Z)-2d did not afford the desired coupling product (S,E)-4m. Increasing the loading of K2CO3 to 4.5 equiv solved the problem (Table 5, entry 1). Under the same conditions (standard conditions B), n-hexylboronic acid could easily couple with (S,Z)-2d affording (S,E)-4n in 72% yield (Table 5 entry 2).
![]() | (3) |
|
|
||||||
|---|---|---|---|---|---|---|
| Entry | (S,Z)-2 | 3 | Time (h) | 4 | ||
| R1 | (equiv) | R2 | Yieldb (%) | ee% | ||
a Standard conditions B: a mixture of 1.0 equiv of (S,Z)-2, 2.0 equiv of 3, 4.5 equiv of K2CO3, 0.05 equiv of Pd(OAc)2 and 0.10 equiv of LB-Phos·HBF4 were stirred in toluene–H2O = 10 : 1 at 110 °C.
b Isolated yield.
c PdCl2(LB-Phos)2 (5 mol%) was used as catalyst.
|
||||||
| 1 | Ph (S,Z)-2d | 2.0 | n-Bu (3j) | 3.0 | 73 ((S,E)-4m) | 99.3 |
| 2 | Ph (S,Z)-2d | 2.0 | n-Hex (3k) | 6.0 | 72 ((S,E)-4n) | >99 |
| 3 | n-Bu (Z)-2a | 2.0 | n-Bu (3j) | 8.0 | 23 (4o) | — |
| 4c | n-Bu (S,Z)-2a | 3.0 | n-Bu (3j) | 3.0 | 55 ((S)-4o) | 99.4 |
Furthermore, we found that 2-thienylboronic acid 3l failed to couple with (Z)-2d under the standard conditions A or B (Scheme 1). We reasoned that the formation of Pd–S complex 5 was too stable to prevent the formation of P–Pd species (Scheme 2). Then we synthesized complex PdCl2(LB-Phos)27 by stirring PdCl2(PhCN)2 with LB-Phos in benzene for 3 days at room temperature. Indeed, this problem was also conquered by using PdCl2(LB-Phos)2 (Scheme 3) as the catalyst. (S,Z)-4p8 and (S,Z)-4q could be prepared in 77% and 83% yields, respectively, under these conditions (Scheme 4). The absolute configuration of (S,Z)-4p was further confirmed by X-ray diffraction studies (Fig. 1). It is interesting to note that by using 5 mol% PdCl2(LB-Phos)2 and 3.0 equiv of n-butylboronic acid, the yield of S-4o was also improved to 55% (Table 5, entry 4) as compared with the results presented in entry 3 of Table 5.
![]() | ||
| Scheme 1 | ||
![]() | ||
| Scheme 2 | ||
![]() | ||
| Scheme 3 Synthesis and ORTEP representation of trans-PdCl2(LB-Phos)2. | ||
![]() | ||
| Scheme 4 | ||
![]() | ||
| Fig. 1 ORTEP representation of (S,Z)-4p.8 | ||
:
1 in volume was used, alkyl boronic acid could also be coupled to afford the products in a moderate yields. 2-Benzothienylboronic acid and 2-thienylboronic acid could also be coupled easily in presence of the pre-formed PdCl2(LB-Phos)2. Further studies in this area are being conducted in our laboratory.
:
2, 0.8 mL min−1, λ = 230 nm, tR = 8.4 min (major), 10.2 min (minor)): [α]20D = −45.9 (c = 1.14, CHCl3), 1H NMR (300 MHz, CDCl3) δ 4.89 (d, J = 3.6 Hz, 1H, OCH), 2.34 (t, J = 7.7 Hz, 2H, CH2), 2.24–2.07 (m, 1H, CH), 1.79–1.49 (m, 2H, CH2), 1.44–1.26 (m, 2H, CH2), 1.09 (d, J = 6.9 Hz, 3H, CH3), 0.99 (d, J = 6.9 Hz, 3H, CH3), 0.93 (t, J = 7.2 Hz, 3H. CH3); 13C NMR (75 MHz, CDCl3) δ 161.5, 138.9, 131.9, 83.5, 36.2, 30.9, 28.8, 22.0, 18.4, 15.6, 13.7; IR (neat) ν (cm−1) 2965, 2934, 2876, 1814, 1702, 1467, 1429, 1389, 1370, 1344, 1287, 1216, 1191, 1166, 1109, 1081, 1058; MS (70 ev, EI) m/z (%): 218 (M+(37Cl), 0.33), 216 (M+(35Cl), 0.99), 173 (100); Anal. Calcd For C11H17ClO2: C, 60.97; H, 7.91. Found: C, 61.09; H, 7.97.
The following compounds were prepared according to this procedure.
:
2, 0.8 mL min−1, λ = 230 nm, tR = 14.0 min (major)): [α]20D = −96.1 (c = 1.14, CHCl3); white solid, m.p. 83–84 °C (n-hexane/ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.58–7.51 (m, 2H, Ar–H), 7.51–7.42 (m, 3H, Ar–H), 5.35 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz, 1H, OCH) 1.95–1.78 (m, 1H, one proton in CH2), 1.72–1.52 (m, 1H, one proton in CH2), 0.92 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 161.6, 134.2, 133.5, 132.8, 131.4, 128.9, 128.0, 81.2, 24.4, 8.2; IR (KBr) ν (cm−1) 3063, 2976, 2922, 2871, 1806, 1675, 1588, 1579, 1495, 1461, 1445, 1309, 1267, 1236, 1184, 1151, 1129, 1077, 1060, 1024; MS (70 ev, EI), m/z (%): 224 (M+(37Cl), 12.73), 222 (M+(35Cl), 38.89), 221 (100); Anal. Calcd for C12H11ClO2: C, 64.73; H, 4.98. Found: C, 64.75; H, 4.95.
petroleum ether/ethyl acetate = 100/1, then recrystallization in n-hexane and ethyl acetate): a white solid: m.p. 54–55 °C (n-hexane/ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.58–7.51 (m, 2H, Ar–H), 7.51–7.42 (m, 3H, Ar–H), 5.35 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz, 1H, OCH), 1.95–1.80 (m, 1H, one proton in CH2), 1.72–1.54 (m, 1H, one proton in CH2), 0.92 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 161.7, 134.2, 133.5, 132.7, 131.4, 128.9, 128.0, 81.2, 24.3, 8.3; IR (KBr) ν (cm−1) 2967, 2936, 2920, 2877, 1797, 1675, 1493, 1447, 1436, 1389, 1311, 1269, 1236, 1161, 1134, 1065; MS (70 ev, EI), m/z (%): 224 (M+(37Cl), 12.73), 222 (M+(35Cl), 39.49), 221 (100); Anal. Calcd for C12H11ClO2: C, 64.73; H, 4.98. Found: C, 64.82; H, 4.97.
:
ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 6.12 (s, 4H, Ar–H), 3.89 (s, 12H, 4 × OCH3), 3.83 (s, 6H, 2 × OCH3), 2.96–2.77 (m, 4H, 2 × CH2), 2.24–2.00 (m, 4H, 2 × CH2), 1.90–1.08 (m, 36H, 16 × CH2 and 4 × CH); 13C NMR (75 MHz, CDCl3) δ 164.4, 163.2, 94.5 (t, J = 19.4 Hz), 91.0, 55.8, 55.1, 33.4, 29.7, 28.6, 27.5 (t, J = 5.0 Hz), 27.3 (t, J = 7.1 Hz), 26.5; 31P NMR (121 MHz, CDCl3) δ 17.6; IR (KBr) ν (cm−1) 2925, 2848, 1598, 1580, 1465, 1454, 1405, 1331, 1287, 1266, 1225, 1206, 1180, 1160, 1121, 1089, 1034, 1003. MS (ESI-TOF) 871 (C42H6637ClO6P2Pd+, 100), 869 (C42H6635ClO6P2Pd+, 99.11); Anal. Calcd For C42H66Cl2O6P2Pd: C, 55.66; H, 7.34. Found: C, 55.75; H, 7.44.
:
2, 0.8 mL min−1, λ = 230 nm, tR = 9.9 min (major)): [α]20D = −26.1 (c = 1.56, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.57–7.47 (m, 2H, Ar–H), 7.46–7.34 (m, 3H, Ar–H), 5.03 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz, 1H, OCH), 2.60–2.36 (m, 2H, CH2), 2.20–2.04 (m, 1H, one proton in CH2), 1.96–1.78 (m, 1H, one proton in CH2), 1.44–1.24 (m, 4H, 2 × CH2), 1.11 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.3, 148.5, 134.8, 132.1, 129.5, 128.3, 128.0, 79.0, 33.0, 30.0, 26.3, 22.5, 13.7, 8.6; IR (neat) ν (cm−1) 3056, 3028, 2955, 2936, 2873, 1799, 1683, 1577, 1496, 1459, 1446, 1380, 1367, 1312, 1291, 1240, 1159, 1106, 1049, 1014; MS (70 ev, EI) m/z (%): 245 (M+ + 1, 6.32), 244 (M+, 42.33), 145 (100); HRMS Calcd for C16H20O2 (M+): 244.1463. Found 244.1457.
The following compounds were prepared according to these procedures.
:
3, 1.0 mL min−1, 230 nm, tR = 14.9 min (major), 25.8 (minor)); [α]20D = +5.6 (c = 1.01, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.56 (d, J = 9.0 Hz, 2H, Ar–H), 6.93 (d, J = 9.0 Hz, 2H, Ar–H), 5.00 (dd, J1 = 7.7 Hz, J2 = 3.2 Hz, 1H, OCH), 3.83 (s, 3H, OCH3), 2.58–2.29 (m, 2H, CH2), 2.17–2.02 (m, 1H, one proton in CH2), 1.94–1.75 (m, 1H, one proton in CH2), 1.45–1.20 (m, 4H, 2 × CH2), 1.09 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 6.9 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.6, 160.7, 148.1, 130.4, 129.7, 127.0, 113.7, 78.9, 55.2, 32.7, 30.4, 26.4, 22.6, 13.8, 8.6; IR (neat) ν (cm−1) 2958, 2933, 2870, 2838, 1789, 1674, 1605, 1574, 1514, 1463, 1443, 1380, 1301, 1255, 1182, 1157, 1127, 1097, 1040; MS (70 ev, EI) m/z (%): 275 (M+ + 1, 12.52), 274 (M+, 62.30), 175 (100); HRMS Calcd for C17H22O3 (M+): 274.1569. Found 274.1577.
:
3, 0.8 mL min−1, 230 nm, tR = 10.0 min (major)): [α]20D = −25.8 (c = 0.89, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.31 (t, J = 8.1 Hz, 1H, Ar–H), 7.15 (s, 1H, Ar–H), 7.08 (d, J = 3.9 Hz 1H, Ar–H), 6.97–6.89 (m, 1H, Ar–H), 5.01 (dd, J1 = 7.8 Hz, J2 = 2.7 Hz, 1H, OCH), 3.84 (s, 3H, OCH3), 2.58–2.33 (m, 2H, CH2), 2.21–2.02 (m, 1H, one proton in CH2), 1.97–1.77 (m, 1H, one proton in CH2), 1.50–1.23 (m, 4H, 2 × CH2), 1.10 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 6.6 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.2, 159.3, 148.3, 136.1, 132.1, 129.3, 120.1, 115.4, 113.7, 79.0, 55.3, 33.0, 30.1, 26.3, 22.6, 13.8, 8.6; IR (neat) ν (cm−1) 2959, 2930, 2873, 2838, 1801, 1684, 1599, 1579, 1489, 1464, 1430, 1374, 1319, 1290, 1235, 1181, 1153, 1106, 1050; MS (70 ev, EI) m/z (%): 275 (M+ + 1, 18.18), 274 (M+, 100); HRMS Calcd for C17H22O3 (M+): 274.1569. Found 274.1565.
:
2, 0.8 mL min−1, 214 nm, tR = 12.4 min (major), tR = 15.6 min (major)); [α]20D = −16.9 (c = 1.04, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.38–7.27 (m, 1H, Ar–H), 7.16 (dd, J1 = 7.5 Hz, J2 = 1.8 Hz, 1H, Ar–H), 7.02–6.87 (m, 2H, Ar–H), 5.07 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz, 1H, OCH), 3.80 (s, 3H, OCH3), 2.57–2.35 (m, 2H, CH2), 2.20–2.04 (m, 1H, one proton in CH2), 1.97–1.80 (m, 1H, one proton in CH2), 1.36–1.22 (m, 4H, 2 × CH2), 1.11 (t, J = 7.4 Hz, 3H, CH3), 0.84 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.2, 156.3, 147.0, 133.2, 130.1, 130.0, 124.8, 120.3, 110.9, 79.4, 55.4, 33.2, 29.5, 26.2, 22.5, 13.8, 8.4; IR (neat) ν (cm−1) 2955, 2935, 2873, 1806, 1698, 1599, 1580, 1491, 1463, 1435, 1380, 1294, 1243, 1161, 1124, 1093, 1050; MS (70 ev, EI) m/z (%): 275 (M+ + 1, 19.03), 274 (M+, 100); HRMS Calcd for C17H22O3 (M+): 274.1569. Found: 274.1577.
petroleum ether/ethyl acetate = 60/1) as a liquid in ee > 99%, as determined by HPLC (Chiralpak AD-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 10.4 min (major)); [α]20D = −17.0 (c = 0.88, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.61 (d, J = 16.5 Hz, 1H, C
CH), 7.57–7.47 (m, 2H, Ar–H), 7.43–7.27 (m, 3H, Ar–H), 6.90 (d, J = 16.5 Hz, 1H, C
CH), 5.01 (dd, J1 = 7.8 Hz, J2 = 3.3 Hz, 1H, OCH), 2.43–2.26 (m, 2H, CH2), 2.15–1.97 (m, 1H, one proton in CH2), 1.92–1.73 (m, 1H, one proton in CH2), 1.69–1.32 (m, 4H, 2 × CH2), 1.08 (t, J = 7.4 Hz, 3H, CH3), 0.96 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 164.1, 144.9, 135.9, 134.5, 133.1, 129.0, 128.7, 127.3, 123.5, 79.6, 31.5, 28.6, 26.3, 23.0, 13.8, 8.7; IR (neat) ν (cm−1) 3079, 3056, 3037, 3018, 2959, 2933, 2873, 1793, 1670, 1627, 1573, 1492, 1464, 1449, 1378, 1366, 1321, 1295, 1236, 1148, 1125, 1054; MS (70 ev, EI) m/z (%): 271 (M+ + 1, 4.69), 270 (M+, 16.98), 213 (100); HRMS Calcd for C18H22O2 (M+): 270.1620. Found 270.1627.
CH), 7.57–7.50 (m, 2H, Ar–H), 7.43–7.27 (m, 3H, Ar–H), 6.90 (d, J = 16.5 Hz, 1H, C
CH), 5.01 (dd, J1 = 7.8 Hz, J2 = 3.3 Hz, 1H, OCH), 2.44–2.25 (m, 2H, CH2), 2.16–1.97 (m, 1H, one proton in CH2), 1.91–1.73 (m, 1H, one proton in CH2), 1.69–1.34 (m, 4H, 2 × CH2), 1.08 (t, J = 7.4 Hz, 3H, CH3), 0.97 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 164.1, 144.9, 135.9, 134.4, 133.1, 129.0, 128.7, 127.3, 123.4, 79.6, 31.4, 28.6, 26.3, 22.9, 13.8, 8.7; IR (neat) ν (cm−1) 3082, 3060, 3044, 3028, 2959, 2933, 2873, 1791, 1669, 1622, 1576, 1496, 1449, 1374, 1317, 1295, 1236, 1148, 1125, 1094, 1054; MS (70 ev, EI) m/z (%): 271 (M+ + 1, 5.52), 270 (M+, 27.71), 213 (100).
:
2, 0.8 mL min−1, 230 nm, tR = 9.3 min (major)); [α]20D = −10.8 (c = 0.72, CHCl3, Lit. [α]20D = −10.1 (c = 1.0, CHCl3, ee = 99.9%)9): 1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 8.1 Hz, 2H, Ar–H), 7.22 (d, J = 8.1 Hz, 2H, Ar–H), 5.01 (dd, J1 = 7.7 Hz, J2 = 2.9 Hz, 1H, OCH), 2.61–2.31 (m, 5H, CH3 and CH2), 2.20–2.04 (m, 1H, one proton in CH2), 1.95–1.77 (m, 1H, one proton in CH2), 1.45–1.24 (m, 4H, 2 × CH2), 1.11 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.4, 148.6, 139.7, 131.9, 131.3, 129.0, 127.9, 79.0, 32.9, 30.2, 26.3, 22.6, 21.3, 13.7, 8.5; IR (neat) ν (cm−1) 3028, 2959, 2926, 2873, 1798, 1681, 1610, 1564, 1513, 1460, 1380, 1312, 1291, 1239, 1158, 1128, 1095, 1048, 1020; MS (70 ev, EI) m/z (%): 259 (M+ + 1, 5.06), 258 (M+, 28.77), 159 (100).
petroleum ether/ethyl acetate = 50/1) as a liquid: 1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 8.4 Hz, 2H, Ar–H), 7.22 (d, J = 7.8 Hz, 2H, Ar–H), 5.01 (dd, J1 = 7.7 Hz, J2 = 3.2 Hz, 1H, OCH), 2.60–2.26 (m, 5H, CH3 and CH2), 2.20–2.03 (m, 1H, one proton in CH2), 1.95–1.77 (m, 1H, one proton in CH2), 1.45–1.24 (m, 4H, 2 × CH2), 1.11 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.4, 148.6, 139.8, 131.9, 131.3, 129.0, 127.9, 79.0, 32.9, 30.2, 26.3, 22.6, 21.3, 13.8, 8.5; IR (neat) ν (cm−1) 3025, 2959, 2930, 2873, 1798, 1681, 1610, 1564, 1513, 1460, 1380, 1312, 1291, 1239, 1158, 1128, 1095, 1048, 1020; MS (70 ev, EI) m/z (%): 259 (M+ + 1, 5.05), 258 (M+, 27.60), 159 (100).
petroleum ether/ethyl acetate = 40/1) as a liquid in ee > 99%, as determined by HPLC (Chiralpak OD-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 9.0 min (major)); [α]20D = +9.5 (c = 0.97, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 8.1 Hz, 2H, Ar–H), 7.22 (d, J = 8.1 Hz, 2H, Ar–H), 5.12 (q, J = 6.3 Hz, 1H, OCH), 2.60–2.31 (m, 5H, CH3 and CH2), 1.67 (d, J = 6.0 Hz, 3H, CH3), 1.44–1.24 (m, 4H, 2 × CH2), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.3, 148.4, 139.8, 133.0, 131.8, 129.0, 127.9, 74.2, 32.5, 30.2, 22.5, 21.3, 19.5, 13.7; IR (neat) ν (cm−1) 3021, 2957, 2930, 2869, 1798, 1680, 1610, 1513, 1454, 1378, 1339, 1258, 1157, 1107, 1086, 1061, 1014; MS (70 ev, EI) m/z (%): 245 (M+ + 1, 4.22), 244 (M+, 23.54), 143 (100); HRMS Calcd for C16H20O2 (M+): 244.1463. Found 244.1459.
petroleum ether/ethyl acetate = 40/1) as a liquid: 1H NMR (300 MHz, CDCl3) δ 7.51–7.42 (m, 2H, Ar–H), 7.22 (d, J = 7.8 Hz, 2H, Ar–H), 5.12 (q, J = 6.2 Hz, 1H, OCH), 2.60–2.33 (m, 5H, CH3 and CH2), 1.67 (d, J = 6.3 Hz, 3H, CH3), 1.46–1.22 (m, 4H, 2 × CH2), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.2, 148.4, 139.8, 133.0, 131.8, 129.1, 127.9, 74.2, 32.5, 30.2, 22.5, 21.3, 19.5, 13.7; IR (neat) ν (cm−1) 3031, 2957, 2931, 2869, 1798, 1679, 1610, 1513, 1454, 1378, 1339, 1258, 1157, 1107, 1090, 1061, 1014; MS (70 ev, EI) m/z (%): 245 (M+ + 1, 4.54), 244 (M+, 26.94), 143 (100); HRMS Calcd for C16H20O2 (M+): 244.1463. Found: 244.1466.
:
2, 0.8 mL min−1, 230 nm, tR = 12.8 min (major)); [α]20D = −5.1 (c = 2.26, CHCl3); m.p. 83–84 °C (n-hexane); 1H NMR (300 MHz, CDCl3) δ 8.03 (s, 1H, Ar–H), 7.97–7.78 (m, 3H, Ar–H), 7.73–7.61 (m, 1H, Ar–H), 7.59–7.43 (m, 2H, Ar–H), 5.08 (dd, J1 = 7.7 Hz, J2 = 3.2 Hz, 1H, OCH), 2.74–2.43 (m, 2H, CH2), 2.27–2.05 (m, 1H, one proton in CH2), 2.04–1.80 (m, 1H, one proton in CH2), 1.53–1.23 (m, 4H, 2 × CH2), 1.16, (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 6.9 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.3, 148.5, 133.7, 132.8, 132.3, 128.5, 128.0, 127.8, 127.6, 126.8, 126.3, 125.4, 79.1, 33.0, 30.1, 26.3, 22.5, 13.7, 8.6; IR (KBr) ν (cm−1) 3057, 2959, 2933, 2872, 1797, 1681, 1597, 1504, 1461, 1380, 1311, 1239, 1155, 1123, 1097, 1048, 1017; MS (70 ev, EI) m/z (%): 295 (M+ + 1, 10.17), 294 (M+, 47.97), 237 (100); Anal. Calcd for C20H22O2: C, 81.60; H, 7.53. Found: C, 81.82; H, 7.58.
petroleum ether/ethyl acetate = 40/1) as a liquid: 1H NMR (300 MHz, CDCl3) δ 8.03 (d, J = 1.2 Hz, 1H, Ar–H), 7.94–7.79 (m, 3H, Ar–H), 7.71–7.61 (m, 1H, Ar–H), 7.57–7.46 (m, 2H, Ar–H), 5.08 (dd, J1 = 7.8 Hz, J2 = 3.0 Hz, 1H, OCH), 2.72–2.45 (m, 2H, CH2), 2.25–2.06 (m, 1H, one proton in CH2), 2.01–1.82 (m, 1H, one proton in CH2), 1.50–1.24 (m, 4H, 2 × CH2), 1.15 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.3, 148.5, 133.7, 132.9, 132.4, 132.3, 128.6, 128.0, 127.8, 127.6, 126.9, 126.3, 125.4, 79.1, 33.0, 30.2, 26.4, 22.6, 13.8, 8.6; IR (neat) ν (cm−1) 3057, 2959, 2933, 2873, 1798, 1681, 1600, 1501, 1461, 1374, 1308, 1239, 1155, 1123, 1097, 1048, 1014; MS (70 ev, EI) m/z (%): 295 (M+ + 1, 10.23), 294 (M+, 47.88), 237 (100); HRMS Calcd for C20H22O2 (M+): 294.1620. Found: 294.1615.
petroleum ether/ethyl acetate = 40/1) as a liquid in ee > 99%, as determined by HPLC (Chiralpak OD-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 8.1 min (major)): [α]20D = −6.8 (c = 1.02, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.58–7.47 (m, 2H, Ar–H), 7.46–7.32 (m, 3H, Ar–H), 4.98 (d, J = 2.7 Hz, 1H, OCH), 2.63–2.49 (m, 1H, one proton in CH2), 2.49–2.36 (m, 1H, one proton in CH2), 2.36–2.18 (m, 1H, CH), 1.47–1.23 (m, 4H, 2 × CH2), 1.17 (d, J = 7.2 Hz, 3H, CH3), 1.05 (d, J = 6.9 Hz, 3H, CH3), 0.87 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.3, 148.6, 134.9, 131.3, 129.4, 128.2, 127.9, 82.3, 33.2, 30.6, 29.8, 22.5, 18.7, 14.9, 13.6; IR (neat) ν (cm−1) 3059, 3022, 2963, 2932, 2873, 1801, 1682, 1573, 1494, 1466, 1445, 1387, 1375, 1341, 1296, 1244, 1187, 1148, 1105, 1072, 1038: MS (70 ev, EI) m/z (%): 259 (M+ + 1, 3.06), 258 (M+, 21.03), 145 (100); HRMS Calcd for C17H22O2 (M+): 258.1620. Found: 258.1609.
petroleum ether/ethyl acetate = 50/1) as a liquid: 1H NMR (300 MHz, CDCl3) δ 7.55–7.46 (m, 2H, Ar–H), 7.46–7.35 (m, 3H, Ar–H), 4.97 (d, J = 3.0 Hz, 1H, OCH), 2.63–2.34 (m, 2H, CH2), 2.34–2.16 (m, 1H, CH), 1.44–1.23 (m, 4H, 2 × CH2), 1.16 (d, J = 6.9 Hz, 3H, CH3), 1.04 (d, J = 6.9 Hz, 3H, CH3), 0.86 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.4, 148.7, 135.0, 131.4, 129.5, 128.3, 128.0, 82.4, 33.4, 30.7, 29.9, 22.6, 18.8, 15.0, 13.7; IR (neat) ν (cm−1) 2963, 2932, 2873, 1801, 1682, 1489, 1465, 1445, 1383, 1338, 1244, 1185, 1147, 1105, 1068, 1038: MS (70 ev, EI) m/z (%): 259 (M+ + 1, 3.42), 258 (M+, 21.00), 145 (100); HRMS Calcd for C17H22O2 (M+): 258.1620. Found: 258.1612.
petroleum ether/ethyl acetate = 20/1) as a solid in ee > 99%, as determined by HPLC (Chiralpak OJ-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 35.8 min (major)): [α]20D = +65.1 (c = 1.08, CHCl3); m.p. 68–69 °C (n-hexane/ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.55–7.47 (m, 2H, Ar–H), 7.45–7.35 (m, 3H, Ar–H), 7.29–7.18 (m, 2H, Ar–H), 6.94–6.85 (m, 2H, Ar–H), 5.17 (dd, J1 = 7.2 Hz, J2 = 3.3 Hz, 1H, OCH), 3.84 (s, 3H, OCH3), 1.64–1.47 (m, 1H, one proton in CH2), 1.46–1.30 (m, 1H, one proton in CH2), 0.85 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.8, 161.1, 146.7, 137.7, 131.8, 130.8, 129.3, 129.2, 128.6, 128.2, 113.6, 79.6, 55.3, 24.7, 8.1; IR (KBr) ν (cm−1) 3053, 2971, 2931, 2908, 2876, 2841, 1783, 1650, 1604, 1513, 1493, 1459, 1445, 1297, 1257, 1174, 1161, 1128, 1077, 1064, 1023; MS (70 ev, EI) m/z (%): 295 (M+ + 1, 18.33), 294 (M+, 90.71), 265 (100); HRMS Calcd for C19H18O3 (M+): 294.1256. Found: 294.1255.
petroleum ether/ethyl acetate = 40/1) as a solid: m.p. 97–98 °C (n-hexane/ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.56–7.47 (m, 2H, Ar–H), 7.45–7.35 (m, 3H, Ar–H), 7.29–7.19 (m, 2H, Ar–H), 6.94–6.85 (m, 2H, Ar–H), 5.17 (dd, J1 = 7.2 Hz, J2 = 3.6 Hz, 1H, OCH), 3.84 (s, 3H, OCH3), 1.64–1.48 (m, 1H, one proton in CH2) 1.48–1.30 (m, 1H, one proton in CH2), 0.85 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.8, 161.1, 146.7, 137.7, 131.8, 130.8, 129.3, 129.2, 128.6, 128.2, 113.6, 79.5, 55.3, 24.7, 8.1; IR (KBr) ν (cm−1) 2996, 2968, 2962, 2932, 2873, 2834, 1802, 1670, 1606, 1514, 1456, 1441, 1389, 1320, 1272, 1250, 1182, 1161, 1125, 1077, 1053, 1029; MS (70 ev, EI) m/z (%): 295 (M+ + 1, 19.56), 294 (M+, 92.91), 265 (100); Anal. Calcd for C19H18O3 (M+): C: 77.53, H: 6.16. Found: C: 77.44, H, 5.99.
petroleum ether/ethyl acetate = 40/1) as a liquid in ee > 99%, as determined by HPLC (Chiralpak AD-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 8.0 min (major), 8.5 min (minor)): [α]20D = −120.7 (c = 1.04, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.45–7.32 (m, 3H, Ar–H), 7.25–7.15 (m, 2H, Ar–H), 7.10 (d, J = 15.9 Hz, 1H, C
CH), 5.84 (dt, J1 = 15.9 Hz, J2 = 7.4 Hz, 1H, C
CH), 4.97 (dd, J1 = 7.1 Hz, J2 = 3.5 Hz, 1H, OCH), 2.18 (q, J = 7.3 Hz, 2H, CH2), 1.59–1.21 (m, 4H, 2 × CH2), 0.89 (t, J = 7.4 Hz, 3H, CH3), 0.78 (t, J = 7.5 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 164.1, 145.0, 143.2, 134.6, 131.3, 128.8, 128.5, 126.7, 79.9, 35.1, 25.3, 22.0, 13.7, 8.2; IR (neat) ν (cm−1), 2964, 2932, 2874, 1795, 1664, 1462, 1444, 1322, 1310, 1301, 1236, 1163, 1106, 1054; MS (70 ev, EI) m/z (%): 257 (M+ + 1, 2.24), 256 (M+, 11.22), 185 (100); HRMS Calcd for C17H20O2 (M+): 256.1463. Found: 256.1458.
petroleum ether/ethyl acetate = 40/1) as a liquid: 1H NMR (300 MHz, CDCl3) δ 7.52–7.32 (m, 3H, Ar–H), 7.25–7.15 (m, 2H, Ar–H), 7.10 (d, J = 15.6 Hz, 1H, C
CH), 5.94–5.74 (m, 1H, C
CH), 4.97 (dd, J1 = 7.1 Hz, J2 = 3.8 Hz, 1H, OCH), 2.18 (q, J = 7.1 Hz, 2H, CH2), 1.57–1.19 (m, 4H, 2 × CH2), 0.89 (t, J = 7.5 Hz, 3H, CH3), 0.78 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 164.1, 145.0, 143.2, 134.6, 131.3, 128.8, 128.5, 126.7, 79.9, 35.1, 25.3, 22.0, 13.7, 8.3; IR (neat) ν (cm−1) 2964, 2931, 2869, 1794, 1665, 1629, 1462, 1444, 1382, 1322, 1304, 1293, 1236, 1163, 1106, 1073, 1054; MS (70 ev, EI) m/z (%): 257 (M+ + 1, 1.52), 256 (M+, 8.33), 185 (100); HRMS Calcd for C17H20O2 (M+): 256.1463. Found: 256.1469.
petroleum ether/ethyl acetate = 30/1) on silica gel and recrystallization (8 mL of n-hexane) afforded (S,E)-4l (42.4 mg, 46%) as a solid in 99.5% ee, as determined by HPLC (Chiralpak OJ-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, λ = 230 nm, tR = 16.6 min (major), 15.6 min (minor)); [α]20D = −29.0 (c = 1.02, CHCl3): m.p. 87–88 °C (n-hexane); 1H NMR (300 MHz, CDCl3) δ 7.42–7.29 (m, 3H, Ar–H), 7.14–7.00 (m, 2H, Ar–H), 4.78 (dd, J1 = 7.2 Hz, J2 = 3.6 Hz, 1H, OCH), 2.66–2.48 (m, 1H, CH), 1.53–1.21 (m, 2H, CH2), 0.99–0.84 (m, 2H, CH2), 0.84–0.63 (m, 4H, CH3 and one proton in CH2), 0.53–0.37 (m, 1H, one proton in CH2); 13C NMR (75 MHz, CDCl3) δ 164.8, 151.7, 133.5, 131.9, 128.5, 128.3, 127.8, 79.9, 25.5, 14.9, 8.3, 6.9, 6.2; IR (KBr) ν (cm−1) 3087, 3012, 2987, 2963, 2940, 2922, 2878, 1792, 1697, 1489, 1463, 1441, 1420, 1306, 1235, 1194, 1168, 1119, 1055, 1011; MS (70 ev, EI) m/z (%): 229 (M+ + 1, 2.36), 228 (M+, 14.38), 153 (100); Anal. Calcd for C15H16O2: C, 78.92; H, 7.06. Found: C, 79.08; H, 7.36.
The following compounds were prepared according to this procedure.
petroleum ether/ethyl acetate = 30/1, then recrystallization in 8 mL n-hexane) as a solid: m.p. 68–69 °C (n-hexane); 1H NMR (300 MHz, CDCl3) δ 7.42–7.28 (m, 3H, Ar–H), 7.14–6.98 (m, 2H, Ar–H), 4.78 (dd, J1 = 7.2 Hz, J2 = 3.9 Hz, 1H, OCH), 2.66–2.49 (m, 1H, CH), 1.53–1.18 (m, 2H, CH2), 0.99–0.83 (m, 2H, CH2), 0.83–0.63 (m, 4H, CH3 and one proton in CH2), 0.53–0.35 (m, 1H, one proton in CH2); 13C NMR (75 MHz, CDCl3) δ 164.8, 151.7, 133.5, 131.9, 128.5, 128.3, 127.8, 79.9, 25.5, 14.9, 8.3, 6.9, 6.2; IR (KBr) ν (cm−1) 3009, 2965, 2940, 2917, 2873, 1790, 1695, 1603, 1496, 1461, 1435, 1312, 1261, 1235, 1194, 1169, 1119, 1094, 1056, 1042, 1012; MS (70 ev, EI) m/z (%): 229 (M+ + 1, 2.15), 228 (M+, 13.49), 153 (100); Anal. Calcd for C15H16O2: C, 78.92. H, 7.06. Found: C, 78.94; H, 7.14.
:
1 (300 mL), then n-hexane/ethyl acetate = 100/1)) afforded (S,E)-4m (35.5 mg, 73%) as a liquid in ee 99.3%, as determined by HPLC (Chiralpak AD-H, n-hexane–i-PrOH = 98
:
2, 0.8 mL min−1, 230 nm, tR = 10.7 min (major)): [α]20D = +23.4 (c = 0.94, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.47–7.35 (m, 3H, Ar–H), 7.34–7.24 (m, 2H, Ar–H), 5.20 (dd, J1 = 7.2 Hz, J2 = 3.3 Hz, 1H, OCH), 3.28–3.07 (m, 1H, one proton in CH2), 2.82–2.65 (m, 1H, one proton in CH2), 1.78–1.57 (m, 1H, one proton in CH2), 1.56–1.24 (m, 5H, 2 × CH2 and one proton in CH2), 0.94–0.71 (m, 6H, 2 × CH3); 13C NMR (75 MHz, CDCl3) δ 164.7, 149.1, 136.3, 132.4, 129.3, 128.8, 127.2, 80.5, 31.5, 30.5, 24.7, 22.2, 13.7, 8.3; IR (neat) ν (cm−1) 2960, 2930, 2870, 2860, 1797, 1687, 1459, 1442, 1378, 1309, 1239, 1161, 1131, 1088, 1054; MS (70 ev, EI) m/z (%): 245 (M+ + 1, 2.76), 244 (M+, 20.81), 129 (100); HRMS Calcd for C16H20O2 (M+): 244.1463. Found: 244.1458.
The following compounds were prepared according to these procedure.
:
2, 0.8 mL min−1, 230 nm, tR = 7.2 min (major)): [α]20D = +20.6 (c = 1.18, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.48–7.36 (m, 3H, Ar–H), 7.35–7.24 (m, 2H, Ar–H), 5.20 (dd, J1 = 7.1 Hz, J2 = 3.5 Hz, 1H, OCH), 3.25–3.09 (m, 1H, one proton in CH2), 2.83–2.66 (m, 1H, one proton in CH2), 1.77–1.58 (m, 1H, one proton in CH2), 1.53–1.14 (m, 9H, 4 × CH2 and one proton in CH2), 0.93–0.77 (m, 6H, 2 × CH3); 13C NMR (75 MHz, CDCl3) δ 164.7, 149.1, 136.3, 132.4, 129.3, 128.8, 127.2, 80.5, 31.8, 31.4, 28.7, 28.4, 24.7, 22.4, 14.0, 8.3; IR (neat) ν (cm−1) 3059, 2957, 2929, 2858, 1798, 1688, 1603, 1578, 1495, 1461, 1445, 1379, 1309, 1239, 1160, 1130, 1090, 1055; MS (70 ev, EI) m/z (%): 273 (M+ + 1, 1.33), 272 (M+, 8.97), 143 (100); HRMS Calcd for C18H24O2 (M+): 272.1776. Found: 272.1777.
:
2, 0.8 mL min−1, 230 nm, tR = 6.3 min (major), 8.4 min (minor)): [α]20D = −64.5 (c = 1.21, CHCl3); 1H NMR (300 MHz, CDCl3) δ 4.89 (dd, J1 = 7.5 Hz, J2 = 3.3 Hz, 1H, OCH), 2.60–2.39 (m, 2H, CH2), 2.14–1.90 (m, 3H, CH2 and one proton in CH2), 1.84–1.64 (m, 1H, one proton in CH2), 1.56–1.18 (m, 8H, 4 × CH2), 1.03 (t, J = 7.4 Hz, 3H, CH3), 0.97–0.79 (m, 6H, 2 × CH3); 13C NMR (75 MHz, CDCl3) δ 164.6, 152.0, 131.4, 79.5, 31.7, 30.7, 30.1, 29.5, 26.3, 22.7, 22.4, 13.8, 8.6; IR (neat) ν (cm−1) 2959, 2933, 2874, 2861, 1800, 1709, 1462, 1380, 1310, 1243, 1147, 1123, 1095, 1053, 1013; MS (70 ev, EI) m/z (%): 224 (M+, 2.75), 195 (100); HRMS Calcd for C14H24O2 (M+): 224.1776. Found: 224.1780.
:
2, 1.0 mL min−1, 230 nm, tR = 10.0 min (major), 14.7 min (minor)); [α]20D = −104.6 (c = 1.02, CHCl3); m.p. 72–73 °C (n-hexane and ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J1 = 3.8 Hz, J2 = 0.8 Hz, 1H, Ar–H), 7.53–7.39 (m, 4H, Ar–H), 7.39–7.30 (m, 2H, Ar–H), 7.16–7.08 (m, 1H, Ar–H), 5.00 (dd, J1 = 7.2 Hz, J2 = 3.6 Hz, 1H, OCH), 1.54–1.20 (m, 2H, CH2), 0.83 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.2, 139.5, 139.1, 136.9, 132.2, 130.4, 129.8, 129.4, 128.65, 128.62, 128.1, 79.2, 25.0, 8.1; IR (KBr) ν (cm−1) 2969, 2936, 2871, 1787, 1650, 1462, 1441, 1415, 1374, 1293, 1226, 1154, 1125, 1101, 1052; MS (70 ev, EI) m/z (%): 271 (M+ + 1, 12.60), 270 (M+, 65.41), 240 (100); Anal. Calcd for C16H14O2S: C, 71.08; H, 5.22. Found: C, 70.62; H, 5.16.
The following compounds were prepared according to this procedure.
:
10, 1.0 mL min−1, 230 nm, tR = 9.16 min (major), 17.9 min (minor)): [α]20D = −13.7 (c = 1.12, CHCl3); m.p. 102–103 °C (n-hexane and ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.94 (s, 1H, Ar–H), 7.84–7.74 (m, 2H, Ar–H), 7.54–7.43 (m, 3H, Ar–H), 7.43–7.33 (m, 4H, Ar–H), 5.05 (dd, J1 = 7.2 Hz, J2 = 3.3 Hz, 1H, OCH), 1.58–1.18 (m, 2H, CH2), 0.86 (t, J = 7.4 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 162.8, 141.7, 139.5, 139.2, 138.8, 136.5, 132.3, 129.6, 129.3, 128.7, 126.0, 124.8, 124.7, 122.1, 79.4, 24.9, 8.2; IR (KBr) ν (cm−1) 3058, 3027, 2970, 2937, 2877, 1790, 1651, 1594, 1504, 1457, 1443, 1431, 1343, 1299, 1264, 1239, 1192, 1145, 1120, 1099, 1057, 1030; MS (70 ev, EI) m/z (%): 321 (M+ + 1, 20.28), 320 (M+, 100); Anal. Calcd for C20H16O2S: C, 74.97; H, 5.03. Found: C, 74.77; H, 5.01.
:
5, 1.0 mL min−1, λ = 230 nm, tR = 9.7 min (major)): [α]20D = +6.5 (c = 0.99, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.62–7.46 (m, 2H, Ar–H), 6.97–6.83 (m, 2H, Ar–H), 5.00 (dd, J1 = 7.7 Hz, J2 = 2.9 Hz, 1H, OCH), 3.83 (s, 3H, OCH3), 2.58–2.29 (m, 2H, CH2), 2.17–2.02 (m, 1H, one proton in CH2), 1.94–1.75 (m, 1H, one proton in CH2), 1.45–1.20 (m, 4H, 2 × CH2), 1.09 (t, J = 7.4 Hz, 3H, CH3), 0.87 (t, J = 6.8 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 163.7, 160.7, 148.1, 130.4, 129.7, 127.0, 113.7, 78.9, 55.2, 32.7, 30.4, 26.4, 22.6, 13.8, 8.6.
, final R indices [I > 2σ(I)], R1 = 0.0290, wR2 = 0.0839; R indices (all data), R1 = 0.0323, wR2 = 0.0881; a = 12.8490(5) Å, b = 13.1603(5) Å, c = 17.5483(6) Å, α = 73.847(1)°, β = 68.570(1)°, γ = 65.921(1)°, V = 2492.57(16) Å3. T = 296 K, wavelength: 0.71073 Å, Z = 2, reflections collected/unique: 29003/8738. (Rint = 0.0178); number of observations [>2σ(I)] 8018, parameters: 526. Supplementary crystallographic data have been deposited at the Cambridge Crystallographic Data Centre, CCDC: 888344.Footnote |
| † Electronic supplementary information (ESI) available. CCDC 888344, 888345. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c2ob26365c |
| This journal is © The Royal Society of Chemistry 2013 |